8-Ethyl-2-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one, 95%, 50mg

2-Oxo-2,3-dihydrothiazole-4-carboxylic acid, 98%, 1g

1,1':4',1''-Terphenyl-2-boronic acid, 97.0%, 10g

1-(5-Bromopyridin-2-yl)-2,2,2-trifluoroethan-1-amine hydrochloride, 500mg

Filtration unit with cellulose nitrate membrane Pore size 0.8 μm, with grid, 150 ml, 150 ml, 50 mm, 12 Piece(s)

2-(5-Bromo-2-chlorophenyl)acetic acid, 95.0%, 10g

4-Nitrophenyl beta-D-Xylopyranoside [Substrate for beta-Xylosidase]>98.0%(HPLC)100mg

tert-Butyl 3-amino-4-cyanopyrrolidine-1-carboxylate, 95%, 5g

2-Chloro-1-[1-(3-methoxypropyl)-2,5-dimethyl-1h-pyrrol-3-yl]ethan-1-one, 97%, 250mg

2-Bromopyridine-3-boronic acid, 97.0%, 25g

Balsalazide Disodium Salt Dihydrate>98.0%(HPLC)(N)1g

3'-chloro-3-(2-methoxyphenyl)propiophenone, 97.0%, 1g

1-(2,4-Dichlorophenyl)urea, 97%, 250mg